Trade tariff on medicines would sharply raise import costs and prompt supply chain shifts with cross border economic consequences.
A 100% tariff on medicines exported from India to the U.S. would double the landed cost of affected products absent absorption, compressing exporters' margins and prompting export reorientation, local manufacturing or market diversification. The measure would threaten foreign exchange earnings, employment in manufacturing hubs, and industry R&D, while raising drug prices and supply risk in the U.S. Exemptions, scope and timing, plus policy responses, would determine the ultimate commercial and diplomatic effects. (AI Summary)
A 100% tariff on medicines exported from India to the U.S. would double the landed cost of affected products absent absorption, compressing exporters' margins and prompting export reorientation, local manufacturing or market diversification. The measure would threaten foreign exchange earnings, employment in manufacturing hubs, and industry R&D, while raising drug prices and supply risk in the U.S. Exemptions, scope and timing, plus policy responses, would determine the ultimate commercial and diplomatic effects. (AI Summary)
TaxTMI